Viridian Therapeutics, Inc.\de
VRDN
Revenue
4.78M
▲3.59M▲301.34%
3 Months ChangeAssets
899.42M
▲322.28M▲55.84%
3 Months ChangeLiabilities
177.25M
▲103.08M▲138.99%
3 Months ChangeFree Cash Flow
-92.74M
▼-47.52M▼-105.07%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001193125-26-073391
2025-11-05
Form 10-Q
ID: 0001590750-25-000020
2025-11-05
Form 8-K
ID: 0001193125-25-265711
2025-10-23
Form 8-K
ID: 0001193125-25-247410
2025-10-21
Form 8-K
ID: 0001193125-25-245206
2025-10-20
Form 8-K
ID: 0001193125-25-243039
2025-08-06
Form 10-Q
ID: 0001590750-25-000012
2025-08-06
Form 8-K
ID: 0001193125-25-173983
2025-07-30
Form 8-K
ID: 0001193125-25-168614
2025-06-24
Form 8-K
ID: 0001193125-25-145741